1. Dickler, A, Dowlatshahi, K. Xoft Axxent electronic brachytherapy. Expert Rev. Med. Devices. 2009; 6: 27–31.
2. Vaidya, J S, Baum, M, Tobias, J S, Morgan, S, De Souza, D. The novel technique of delivering targeted intraoperative radiotherapy-target for early breast cancer. Eur. J. Surg. Oncol. 2002; 28: 447–454.
3. Dinsmore, M, Harte, K J, Sliski, A P et al. A new miniature X-ray source for interstitial radiosurgery: device description. Med. Phys. 1996; 23: 45–52.
4. Dickler, A, Ivanov, O, Francescatti, D. Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing Xoft Axxent electronic brachytherapy. World J. Surg. Oncol. 2009; 7: 24–26.
5. Kasper, M E, Chaudhary, A A. Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy. Med Devices 2015; 8: 493–502.
6. Richardson, S, García-Ramírez, J, Lu, W, Myerson, R J, Parikh, P. Design and dosimetric characteristics of a new endocavitary contact radiotherapy system using an electronic brachytherapy source. Med. Phys. 2012; 39: 6838–6846.
7. Dooley, W C, Thropay, J P, Schreiberg, G J et al. Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study. Onco Targets Ther 2010; 3: 197–203.
8. Gerbaulet, A, Pötter, R, Mazeron, J J, Meertens, H, Van Limbergen, E. The GEC-ESTRO handbook of brachytherapy. ESTRO; Brussels 2002: 365–403.
9. Mobit, P N, Nguyen, A, Packianathan, S, He, R, Yang, CC. Dosimetric comparison of brachytherapy sources for high dose rate treatment of endometrial cancer: 192Ir, 60Co and an electronic brachytherapy source. Br J Radiol 2016; 89: 1059.
10. Dickler, A, Kirk, M C, Coon, A et al. A dosimetric comparison of Xoft Axxent electronic brachytherapy and iridium-192 high dose rate brachytherapy in the treatment of endometrial cancer. Brachytherapy 2008; 7: 351–354.
11. Mobit, P N, Packianathan, S, He, R, Yang, C C. Comparison of Axxent-Xoft, 192Ir and 60Co high dose rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer. Br J Radiol. 2015; 88: 1052, 20150010.
12. Ahmad, S, Johnson, E, Hiatt, J R et al. Comparison of tumor and normal tissue dose from eBx and Ir-192 during APBI. J Appl Clin Med Phys 2010; 11: 155–161.
13. Eaton, D J, González, R, Duck, S, Keshtgar, M. Radiation protection for an intra-operative X-ray device. Br J Radiol 2011; 84: 1034–1039.
14. Nack, S, Eriksson, B, Parikh, S, Gupta, N, Varia, M, Glasgow, G. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48: 779–790.
15. Nath, R, Anderson, LL, Luxton, G, Weaver, K A, Williamson, J F, Meigooni, A S. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med. Phys. 1995; 22: 209–234.
16. Rivard, M J, Coursey, B M, DeWerd, L A et al. Update of AAPM task group no. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Med. Phys. 2004; 31: 633–674.
17. Granero, D, Pérez-Calatayud, J, Ballester, F. Technical note: dosimetric study of a new Co-60 source used in brachytherapy. Med Phys 2007; 34: 3485–3488.
18. Hiatt, J R, Rivard, M J, Hughes, H G. Simulation evaluation of NIST air-kerma rate calibration standard for electronic brachytherapy. Med. Phys. 2016; 43: 1119–1129.
19. Cox, J D, Stetz, J, Pajak, T F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–1346.
20. Reniers, B, Liu, D, Rusch, T, Verhaegen, F. Calculation of relative biological effectiveness of a low-energy electronic brachytherapy source. Phys. Med. Biol. 2008; 53: 7125–7135.
21. Brenner, D J, Leu, C S, Beatty, J F, Shefer, R E. Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices. Phys. Med. Biol. 1999; 44: 323–333.
22. White, S A, Reniers, B, de Jong, E E, Rusch, T, Verhaegen, F. A comparison of the relative biological effectiveness of low energy electronic brachytherapy sources in breast tissue: a Monte Carlo study. Phys. Med. Biol. 2016; 61: 383–399.
23. Dickler, A, Puthawala, M Y, Thropay, J P, Bhatnagar, A, Schreiber, G. Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer. Radiat. Oncol 2010; 5: 67.
24. Beaulieu, L, Tedgren, A C, Carrier, J F et al. Report of the task group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med. Phys. 2012; 39: 6208–6236.
25. Shi, C, Guo, B, Cheng, C Y, Eng, T, Papanikolaou, N. Applications of tissue heterogeneity corrections and biologically effective dose volume histograms in assessing the doses for accelerated partial breast irradiation using an electronic brachytherapy source. Phys. Med. Biol. 2010; 55: 5283–5297.
26. Rava, P, Dvorak, T, Markelewicz, R J et al. A comparison of the biological effective dose of 50-kV electronic brachytherapy with 192Ir high-dose-rate brachytherapy for vaginal cuff irradiation. Brachytherapy 2012; 11: 402–407.
27. Ballester-Sánchez, R, Pons-Llanas, O, Candela-Juan, C et al. Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. J. Contemp. Brachytherapy 2016; 8: 48–55.
28. Eaton, D J. Electronic brachytherapy—current status and future directions. Br J Radiol 2015; 88: 1049.